跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAMCEVI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CAMCEVI
Authorized
STANDARD
CAMCEVI
Accord Healthcare Inc
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
25dc16ead47ba9a3
Company
Accord Healthcare Inc
Type
Standard
Approval Details
Approval Id
25dc16ead47ba9a3
Drug Approval Canada Name
CAMCEVI
Product Name
CAMCEVI
Status
Approved
Status Date
2026-03-31
Drug Class
Human
Dosage Form
Emulsion (Extended-Release)
Route Of Administration
Subcutaneous
Schedule
PRESCRIPTION
Ahfs
68:18.08
Atc Original
L02AE02 LEUPRORELIN
Aig Number
0163277002
Company Name
Accord Healthcare Inc
Company Address
3535 Boulevard St-Charles, Suite 704 Kirkland Quebec Canada H9H 5B9
Company Detail Path
/organization/accord-healthcare-inc
Company Information
Pharmaceutical Company Name
Accord Healthcare Inc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
704-3535 boul Saint-Charles
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
25dc16ead47ba9a3
Type
Standard
Back to Health Canada Approvals